002900.SZ
Harbin Medisan Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.15
+2.76%Year over year
Reported trailing growth
- Revenue
- -25.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -57.3%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.4%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +10.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026